Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma

Leukemia and Lymphoma

Volumn 56, Issue 4, 2015, Pages 1072-1078

  Morishima, Satoko ^a,b   Nakamura, Shigeo ^c   Yamamoto, Kazuhito ^b   Miyauchi, Hidemasa ^d   Kagami, Yoshitoyo ^b,e   Kinoshita, Tomohiro ^b,f   Onoda, Hiroshi ^b   Yatabe, Yasushi ^b   Ito, Masafumi ^g   Miyamura, Kouichi ^g   Nagai, Hirokazu ^h   Moritani, Suzuko ^h   Sugiura, Isamu ⁱ   Tsushita, Keitaro ^j   Mihara, Hidetsugu ^k   Ohbayashi, Kaneyuki ^l   Iba, Sachiko ^a   Emi, Nobuhiko ^a   Okamoto, Masataka ^a   Iwata, Seiko ^f   Kimura, Hiroshi ^f   Kuzushima, Kiyotaka ^b   Morishima, Yasuo ^b   more..

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d Nagoya University Hospital ^*  (Japan)

^e Department of Clinical Laboratory   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

ⁱ TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^j CHUKYO HOSPITAL   (Japan)

^k AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l Nishio Municipal Hospital   (Japan)

more..

Author keywords

EBV DNA load; EBV positive diffuse large B cell lymphoma; IFN secretion; Immune response; T cell proliferation

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; GAMMA INTERFERON; IMMUNOGLOBULIN G; VIRUS DNA; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS POSITIVE DIFFUSE LARGE B CELL LYMPHOMA; EX VIVO STUDY; FEMALE; HUMAN; IN VITRO STUDY; LARGE CELL LYMPHOMA; LYMPHOBLASTOID CELL LINE; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; VERY ELDERLY; VIRUS LOAD; B LYMPHOCYTE; BLOOD; CELL CULTURE; CELL PROLIFERATION; CLINICAL TRIAL; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; FLOW CYTOMETRY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LYMPHOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; METABOLISM; PHYSIOLOGY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LYMPHOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; T-LYMPHOCYTES; VIRAL LOAD;

EID: 84929087777     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.938326     Document Type: Article

References (26)

1. Hislop AD, Taylor GS, Sauce D, et al. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007;25:587-617.
2. Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IRAC; 2008.
3. Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16-26.
4. Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007;13:5124-5132.
5. Angulo R, Fulcher DA. Measurement of Candida-specific blastogenesis: comparison of carboxyfluorescein succinimidyl ester labelling of T cells, thymidine incorporation, and CD69 expression. Cytometry 1998;34:143-151.
6. Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37:132-136.
7. Wherry EJ. T cell exhaustion. Nat Immunol 2011;12:492-499.
8. Guppy AE, Rawlings E, Madrigal JA, et al. A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8 + T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease. Transplantation 2007;84:1534-1539.
9. Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol 2012;12:136-148.
10. Long HM, Zuo J, Leese AM, et al. CD4 + T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells. Blood 2009;114:807-815.
11. Demachi-Okamura A, Ito Y, Akatsuka Y, et al. Epstein-Barr virus nuclear antigen 1-specific CD4 + T cells directly kill Epstein-Barr virus-carrying natural killer and T cells. Cancer Sci 2008;99:1633-1642.
12. Pender MP, Csurhes PA, Pfluger CM, et al. CD8 + T cells far predominate over CD4 + T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines. Blood 2012;120:5085-5087.
13. Gandhi MK, Lambley E, Burrows J, et al. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res 2006;12:460-464.
14. Suzuki R, Yamaguchi M, Izutsu K, et al. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type. Blood 2011;118:6018-6022.
15. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461-2470.
16. Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 2011;117:4726-4735.
17. Ouyang Q, Wagner WM, Walter S, et al. An age-related increase in the number of CD8 + T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 2003;124:477-485.
18. Khan N, Hislop A, Gudgeon N, et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 2004;173:7481-7489.
19. Narimatsu H, Ota Y, Kami M, et al. Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients. Ann Oncol 2007;18:122-128.
20. Kanno H, Naka N, Yasunaga Y, et al. Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts. Am J Pathol 1997;150:349-357.
21. Takegawa S, Jin Z, Nakayama T, et al. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder. Cancer Sci 2008;99:296-302.
22. White RE, Ramer PC, Naresh KN, et al. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest 2012;122:1487-1502.
23. Fogg MH, Wirth LJ, Posner M, et al. Decreased EBNA-1-specific CD8 + T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma. Proc Natl Acad Sci USA 2009;106:3318-3323.
24. Heller KN, Arrey F, Steinherz P, et al. Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1. Int J Cancer 2008;123:2824-2831.
25. Raab-Traub N. Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2012;2:453-458.
26. Long HM, Taylor GS, Rickinson AB. Immune defence against EBV and EBV-associated disease. Curr Opin Immunol 2011;23:258-264.